f Post-Approval Studies (PAS) Database
Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Post-Approval Studies (PAS) Database
  • Print
  • Share
  • E-mail
-

The FDA has the authority to require sponsors to perform a post-approval study (or studies) at the time of approval of a premarket approval (PMA), humanitarian device exemption (HDE), or product development protocol (PDP) application. Post-approval studies can provide patients, health care professionals, the device industry, the FDA and other stakeholders information on the continued safety and effectiveness (or continued probable benefit, in the case of an HDE) of approved medical devices. This database allows you to search Post-Approval Study information by applicant or device information.

Learn more...


           

Pinnacle CoMplete Acetabular Hip System


Suggest Enhancement / Report Issue | export reports to excelExport to Excel
General
Study Status Terminated
Application Number /
Requirement Number		 P090002 / PAS001
Date Original Protocol Accepted 11/04/2011
Date Current Protocol Accepted 11/04/2011
Study Name Pinnacle CoMplete Acetabular Hip System
Device Name PINNACLE COMPLETE ACETABULAR HIP SYSTEM
General Study Protocol Parameters
Study Design Prospective Cohort Study
Data Source New Data Collection
Comparison Group Historical Control
Analysis Type Analytical
Study Population Adult: >21
Detailed Study Protocol Parameters
Study Objectives The study design is a prospective, multi-center cohort study
Study Population The study population is comprised of patients implanted with the Pinnacle CoMplete Acetabular System.
Sample Size The sample size is 250 patients.
Key Study Endpoints The primary endpoint is device survivorship. The secondary objective is to evaluate five year cobalt and chromium median metal ion levels along with renal function indicators to include BUN levels and creatinine levels.
Follow-up Visits and Length of Follow-up 10 years.
Patients will receive clinical examination postoperatively at 4 weeks, 3 months, and 1, 2, 3,4, 5, 8, and 10 years. Patients will undergo radiographic examination at 4 weeks, and 1, 2, 3, 4, 5, 8, and 10 postoperative years. For patients in the metal ion study, metal ion testing and renal function testing will occur preoperatively and postoperatively at 1, 2, 5, 8, and 10 postoperative years.


Pinnacle CoMplete Acetabular Hip System Reporting Schedule

Reporting Schedule
Report
Date Due
FDA Receipt
Date
Applicant's Reporting Status
six month report 12/12/2011 12/09/2011 On Time
one year report 06/12/2012 06/14/2012 Overdue/Received
18 month report 12/11/2012 12/14/2012 Overdue/Received
two year report 06/12/2013 06/13/2013 Overdue/Received


Contact Us
Mandated Studies Program
Food and Drug Administration
10903 New Hampshire Ave.
Silver Spring, MD 20993-0002
Email: MandatedStudiesPrograms@fda.hhs.gov

Additional Resources

-
-